scispace - formally typeset
L

Laurent Yvan-Charvet

Researcher at French Institute of Health and Medical Research

Publications -  98
Citations -  10140

Laurent Yvan-Charvet is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: ABCA1 & Cholesterol. The author has an hindex of 42, co-authored 90 publications receiving 8417 citations. Previous affiliations of Laurent Yvan-Charvet include University of Washington & Pierre-and-Marie-Curie University.

Papers
More filters
Journal ArticleDOI

Cholesterol, inflammation and innate immunity

TL;DR: Therapeutic interventions such as increased production or infusion of high-density lipoproteins may sever the links between cholesterol accumulation and inflammation, and have beneficial effects in patients with metabolic diseases.
Journal ArticleDOI

Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport

TL;DR: High-density lipoprotein has been proposed to have several antiatherosclerotic properties, including the ability to mediate macrophage cholesterol efflux, antioxidant capacity, antiinflammatory properties, nitric oxide–promoting activity, and ability to transport proteins with their own intrinsic biological activities.
Journal ArticleDOI

ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation

TL;DR: The findings indicate that ABCA1, ABCG1, and HDL inhibit the proliferation of hematopoietic stem and multipotential progenitor cells and connect expansion of these populations with leukocytosis and accelerated atherosclerosis.
Journal ArticleDOI

Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses

TL;DR: These studies have shown that the traditional roles of HDL and ABC transporters in cholesterol efflux and reverse cholesterol transport are mechanistically linked to antiinflammatory and immunosuppressive functions of HDL.
Journal ArticleDOI

Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.

TL;DR: The results suggest that the combined effects of ABCA1 and ABCG1 in mediating macrophage sterol efflux are central to the antiatherogenic properties of HDL.